Recombinant human thyrotropin in veterinary medicine: current use and future perspectives.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Veterinary Internal Medicine

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1939-1676.2012.00950.xPMID 22676297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH

  2011cited by this paper
• Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake

  2011cited by this paper
• Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.

  2010cited by this paper
• Short-term effect of recombinant human thyroid-stimulating hormone on thyroid volume and echogenicity in healthy beagles.

  2010cited by this paper
• Congenital hypothyroidism in a kitten resulting in decreased IGF-I concentration and abnormal liver function tests

  2010cited by this paper
• Thyroid stimulation with recombinant human thyrotropin in healthy cats, cats with non-thyroidal illness and in cats with low serum thyroxin and azotaemia after treatment of hyperthyroidism

  2010cited by this paper
• Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism.

  2010cited by this paper
• Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer

  2010cited by this paper
• Effect of recombinant human thyroid stimulating hormone on serum thyroxin and thyroid scintigraphy in euthyroid cats

  2009cited by this paper
• Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.

  2009cited by this paper
• Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

  2009cited by this paper
• Comparison of 2 doses of recombinant human thyrotropin for thyroid function testing in healthy and suspected hypothyroid dogs.

  2009cited by this paper
• Diagnosis of hyperthyroidism in cats with mild chronic kidney disease.

  2008cited by this paper
• Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity

  2008cited by this paper
• Functional and morphological changes in the adenohypophysis of dogs with induced primary hypothyroidism: loss of TSH hypersecretion, hypersomatotropism, hypoprolactinemia, and pituitary enlargement with transdifferentiation.

  2008cited by this paper
• Recombinant human thyrotropin administration enhances thyroid uptake of radioactive iodine in hyperthyroid cats.

  2008cited by this paper
• Review on the Occasion of a Decade of Recombinant Human TSH: Prospects and Novel Uses

  2008cited by this paper
• Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.

  2008cited by this paper
• Assessment of thyroid function in dogs with low plasma thyroxine concentration.

  2007cited by this paper
• Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy

  2007cited by this paper
• Thyroid tumors in dogs and cats.

  2007cited by this paper
• Recombinant thyrotropin in the diagnosis of congenital hypothyroidism.

  2007cited by this paper
• Non-surgical treatment of feline hyperthyroidism: options and considerations

  2007cited by this paper
• Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences.

  2007cited by this paper
• Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in healthy, hypothyroid and euthyroid sick dogs.

  2007cited by this paper
• Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

  2006cited by this paper
• Comparison of the biological activity of recombinant human thyroid-stimulating hormone with bovine thyroid-stimulating hormone and evaluation of recombinant human thyroid-stimulating hormone in healthy dogs of different breeds.

  2006cited by this paper
• Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

  2006cited by this paper
• Radioiodine treatment of hyperthyroidism.

  2006cited by this paper
• Stimulation med 0,3 mg rekombinant human thyrotropin øger effekten af 131 I-behandling hos patienter med atoksisk nodulaer struma. En prospektiv, randomiseret, dobbeltblindet undersøgelse--sekundaerpublikation

  2006cited by this paper
• Effect of storage of reconstituted recombinant human thyroid-stimulating hormone (rhTSH) on thyroid-stimulating hormone (TSH) response testing in euthyroid dogs.

  2006cited by this paper
• Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot.

  2006cited by this paper
• 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.

  2006cited by this paper
• Cloning and sequencing of feline thyrotropin (fTSH): heterodimeric and yoked constructs.

  2006influential reference
• Identifying removable radioactivity on the surface of cats during the first week after treatment with iodine 131.

  2006cited by this paper
• [Stimulation with 0,3 mg recombinant human thyrotropin (rhTSH) increases the effect of 131I therapy in patients with nontoxic nodular goiter. A prospective, randomized, double-blind trial--secondary publication].

  2006cited by this paper
• Evaluation of recombinant human thyroid-stimulating hormone to test thyroid function in dogs suspected of having hypothyroidism.

  2006cited by this paper
• Thyroid-Stimulating Hormone–Stimulated Fused Positron Emission Tomography/Computed Tomography in the Evaluation of Recurrence in 131I-Negative Papillary Thyroid Carcinoma

  2006cited by this paper
• Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990-2003).

  2006cited by this paper
• Recombinant Human Thyrotropin-Assisted Radioiodine Therapy for Patients with Metastatic Thyroid Cancer Who Could Not Elevate Endogenous Thyrotropin or Be Withdrawn from Thyroxine

  2006cited by this paper
• A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.

  2006cited by this paper
• Radioiodide (131I) therapy for the treatment of canine thyroid carcinoma.

  2005cited by this paper
• rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

  2005cited by this paper
• Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990-2002).

  2005cited by this paper
• Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report.

  2005cited by this paper
• Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter.

  2004cited by this paper
• Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.

  2004cited by this paper
• Epidemiologic study of relationships between consumption of commercial canned food and risk of hyperthyroidism in cats.

  2004cited by this paper
• Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.

  2004cited by this paper
• Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial.

  2004cited by this paper
• Relationship between orally administered dose, surface emission rate for gamma radiation, and urine radioactivity in radioiodine-treated hyperthyroid cats.

  2003cited by this paper
• Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during l‐thyroxine replacement

  2003cited by this paper
• Klinische, hämatologische, biochemische und endokrinologische Aspekte bei 32 Hunden mit Hypothyreose

  2003cited by this paper
• Evaluation of thyroid function in obese dogs and in dogs undergoing a weight loss protocol.

  2003cited by this paper
• Evaluation of relationships between pretreatment patient variables and duration of isolation for radioiodine-treated hyperthyroid cats.

  2003cited by this paper
• Use of recombinant human thyroid-stimulating hormone for thyrotropin-stimulation testing of euthyroid cats.

  2003cited by this paper
• [Clinical, hematological, biochemical and endocrinological aspects of 32 dogs with hypothyroidism].

  2003cited by this paper
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003cited by this paper
• Influence of drugs on thyroid function in dogs.

  2003cited by this paper
• TSH, the bone suppressing hormone.

  2003cited by this paper
• Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.

  2003cited by this paper
• Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

  2003cited by this paper
• Sodium iodide symporter (NIS) and thyroid.

  2002cited by this paper
• Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer

  2002cited by this paper
• Predictors of response to radioiodine therapy in hyperthyroid cats.

  2002cited by this paper
• Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone

  2002cited by this paper
• Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

  2001cited by this paper
• Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.

  2001cited by this paper
• Measurement of serum concentrations of free thyroxine, total thyroxine, and total triiodothyronine in cats with hyperthyroidism and cats with nonthyroidal disease.

  2001cited by this paper
• Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration.

  2001cited by this paper
• Radioiodine Ablation of Thyroid Remnants After Preparation with Recombinant Human Thyrotropin

  2001cited by this paper
• Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.

  2000cited by this paper
• Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in euthyroid dogs.

  2000cited by this paper
• Is it possible to diagnose canine hypothyroidism?

  1999cited by this paper
• Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.

  1999cited by this paper
• The Effect of Recombinant Human Thyrotropin (rhTSH) on Thyroid Function in Mice and Rats

  1998cited by this paper
• Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.

  1997cited by this paper
• Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

  1997cited by this paper
• Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.

  1997cited by this paper
• Cats and hyperthyroidism.

  1997cited by this paper
• Cats and hyperthyroidism

  1997cited by this paper
• Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.

  1996cited by this paper
• Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.

  1996cited by this paper
• Effect of illness not associated with the thyroid gland on serum total and free thyroxine concentrations in cats.

  1996cited by this paper
• Radioiodine treatment of 524 cats with hyperthyroidism.

  1995cited by this paper
• Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

  1994cited by this paper
• [Serious reactions after the TSH-stimulation test in the dog].

  1992cited by this paper
• Thyrotrophin receptors in normal and neoplastic (primary and metastatic) canine thyroid tissue.

  1992cited by this paper
• The role of the oligosaccharide chains of thyrotropin alpha- and beta-subunits in hormone action.

  1992cited by this paper
• Congenital hypothyroid dwarfism in a family of giant schnauzers.

  1991cited by this paper
• Immunological and biological characteristics of recombinant human thyrotropin.

  1991cited by this paper
• Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells.

  1991cited by this paper
• Congenital hypothyroid dwarfism in a family of giant schnauzers.

  1991cited by this paper
• Effect of nonthyroidal illness on serum thyroxine concentrations in cats: 494 cases (1988).

  1990cited by this paper
• Differential expression and regulation of thyrotropin (TSH) in T cell lines.

  1989cited by this paper
• Canine and Feline Endocrinology and Reproduction

  1988cited by this paper
• Congenital hypothyroidism in Scottish Deerhound puppies.

  1988cited by this paper
• Serum thyroid hormone concentrations fluctuate in cats with hyperthyroidism.

  1987cited by this paper
• Production of human thyroid-stimulating hormone in Chinese hamster ovary cells.

  1987cited by this paper
• In-vivo studies of a human-thyrotrophin preparation.

  1986cited by this paper

• Spontaneous adult-onset primary hypothyroidism in 17 cats

  2025cites this paper
• Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats

  2020cites this paper
• A critical review of food-associated factors proposed in the etiology of feline hyperthyroidism

  2015cites this paper
• Effect of Feeding an Iodine‐Restricted Diet in Cats with Spontaneous Hyperthyroidism

  2015cites this paper
• Abdominal Ultrasound Examination Findings in 534 Hyperthyroid Cats Referred for Radioiodine Treatment Between 2007–2010

  2015cites this paper
• Hypothyroidism in dogs: laboratory findings

  2013cites this paper
• Thyrotropin Suppressive Therapy in Differentiated Thyroid Cancer

  2013cites this paper